{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:34:39Z","timestamp":1791221679825,"version":"4.1.0"},"reference-count":42,"publisher":"Portland Press Ltd.","issue":"4","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,2,1]]},"abstract":"<jats:p>Burn and smoke inhalation-related multiple organ dysfunction is associated with a severe fall in the plasma concentration of antithrombin. Therefore the aim of the present study was to test the hypothesis that intravenous administration of recombinant human antithrombin in combination with aerosolized heparin will ameliorate acute lung injury in sheep exposed to cutaneous burn and smoke inhalation. Sheep were prepared operatively for study and, 7\u00a0days post-surgery, sheep were given a cutaneous burn (40% of total body surface area, third-degree burn) and insufflated with cotton smoke (48 breaths, &amp;lt;40\u00a0\u00b0C) under halothane anaesthesia. After injury, sheep were placed on a ventilator and resuscitated with Ringer's lactate solution. The animals were divided into three groups: sham group (non-injured and non-treated; n=6), saline group (injured and received saline; n=6) and rhAT.iv.+Hep group [injured and treated with rhAT (recombinant human antithrombin) and heparin; n=6]. In the rhAT.iv.+Hep group, rhAT was infused continuously for 48\u00a0h starting 1\u00a0h post-injury with a dose of 0.34\u00a0mg\u00b7h\u22121\u00b7kg\u22121 of body weight and heparin (10000\u00a0units) was aerosolized every 4\u00a0h starting at 1\u00a0h post-injury. The experiment lasted 48\u00a0h. Haemodynamics were stable in sham group, whereas the saline-treated sheep developed multiple signs of acute lung injury, including decreased pulmonary gas exchange, increased inspiratory pressures, extensive airway obstruction and increased pulmonary oedema. These pathological changes were associated with a severe fall in plasma antithrombin concentration, lung tissue accumulation of leucocytes and excessive production of NO. Treatment of injured sheep with anticoagulants attenuated all of the pulmonary pathophysiology observed. In conclusion, the results provide definitive evidence that anticoagulant therapy may be a novel and effective treatment tool in the management of burn patients with concomitant smoke inhalation injury.<\/jats:p>","DOI":"10.1042\/cs20070254","type":"journal-article","created":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T11:18:30Z","timestamp":1200395910000},"page":"321-329","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Combined anticoagulants ameliorate acute lung injury in sheep after burn and smoke inhalation"],"prefix":"10.1042","volume":"114","author":[{"given":"Perenlei","family":"Enkhbaatar","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX 77555, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimalohi","family":"Esechie","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX 77555, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianpu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX 77555, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert\u00a0A.","family":"Cox","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX 77555, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX 77555, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsumori","family":"Hamahata","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX 77555, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Lange","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX 77555, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian\u00a0D.","family":"Traber","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX 77555, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald\u00a0S.","family":"Prough","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX 77555, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David\u00a0N.","family":"Herndon","sequence":"additional","affiliation":[{"name":"Shriners Hospital for Children, Galveston, TX 77550, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel\u00a0L.","family":"Traber","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX 77555, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2008,1,15]]},"reference":[{"key":"2021120120544822700_B1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0076-6879(93)22033-C","article-title":"Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin","volume":"222","author":"Olson","year":"1993","journal-title":"Methods Enzymol."},{"key":"2021120120544822700_B2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2007-995820","article-title":"The anti-inflammatory properties of antithrombin III: new therapeutic implications","volume":"24","author":"Okajima","year":"1998","journal-title":"Semin. Thromb. Hemostasis"},{"key":"2021120120544822700_B3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00003246-200101000-00027","article-title":"Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood","volume":"29","author":"Souter","year":"2001","journal-title":"Crit. Care Med."},{"key":"2021120120544822700_B4","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1182\/blood.V99.5.1638","article-title":"Antithrombin prevents endotoxin-induced hypotension by inhibiting the induction of nitric oxide synthase in rats","volume":"99","author":"Isobe","year":"2002","journal-title":"Blood"},{"key":"2021120120544822700_B5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/bbrc.2001.5534","article-title":"Syndecan-4 as antithrombin receptor of human neutrophils","volume":"287","author":"Kaneider","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021120120544822700_B6","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1160\/TH05-09-0637","article-title":"Antithrombin reduces endotoxin-induced hypotension by enhancing pulmonary sensory neuron activation in rats","volume":"95","author":"Harada","year":"2006","journal-title":"Thromb. Haemostasis"},{"key":"2021120120544822700_B7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0049-3848(97)00291-0","article-title":"Hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma","volume":"89","author":"Garcla-Avello","year":"1998","journal-title":"Thromb. Res."},{"key":"2021120120544822700_B8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0305-4179(99)00099-6","article-title":"Antithrombin III concentrate in the acute phase of thermal injury","volume":"26","author":"Kowal-Vern","year":"2000","journal-title":"Burns"},{"key":"2021120120544822700_B9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0305-4179(01)00011-0","article-title":"Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns","volume":"27","author":"Aoki","year":"2001","journal-title":"Burns"},{"key":"2021120120544822700_B10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.burns.2006.06.011","article-title":"Antithrombin deficiency and its relationship to severe burns","volume":"33","author":"Niedermayr","year":"2007","journal-title":"Burns"},{"key":"2021120120544822700_B11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1164\/rccm.200209-1031PP","article-title":"The inducible nitric oxide synthase inhibitor BBS-2 prevents acute lung injury in sheep after burn and smoke inhalation injury","volume":"167","author":"Enkhbaatar","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021120120544822700_B12","doi-asserted-by":"crossref","first-page":"H2430","DOI":"10.1152\/ajpheart.00055.2003","article-title":"Inducible nitric oxide synthase dimerization inhibitor prevents cardiovascular and renal morbidity in sheep with combined burn and smoke inhalation injury","volume":"285","author":"Enkhbaatar","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021120120544822700_B13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1165\/rcmb.4860","article-title":"Airway obstruction in sheep with burn and smoke inhalation injuries","volume":"29","author":"Cox","year":"2003","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"2021120120544822700_B14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/01.RES.16.5.482","article-title":"Measurement of pulmonary edema","volume":"16","author":"Pearce","year":"1965","journal-title":"Circ. Res."},{"key":"2021120120544822700_B15","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1164\/rccm.200407-953OC","article-title":"The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation","volume":"171","author":"Hollingsworth","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021120120544822700_B16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1054\/bjoc.2000.1357","article-title":"Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas","volume":"83","author":"Mineta","year":"2000","journal-title":"Br. J. Cancer"},{"key":"2021120120544822700_B17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1164\/ajrccm.163.3.9912052","article-title":"Role of nitric oxide in vascular permeability after combined burns and smoke inhalation injury","volume":"163","author":"Soejima","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021120120544822700_B18","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1152\/jappl.1999.86.4.1151","article-title":"Role of L-selectin in physiological manifestations after burn and smoke inhalation injury in sheep","volume":"86","author":"Sakurai","year":"1999","journal-title":"J. Appl. Physiol."},{"key":"2021120120544822700_B19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.shk.0000129201.38588.85","article-title":"Aerosolized tissue plasminogen activator improves pulmonary function in sheep with burn and smoke Inhalation","volume":"22","author":"Enkhbaatar","year":"2004","journal-title":"Shock"},{"key":"2021120120544822700_B20","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1016\/S0021-9258(18)38125-0","article-title":"Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects","volume":"266","author":"Olson","year":"1991","journal-title":"J. Biol. Chem."},{"key":"2021120120544822700_B21","doi-asserted-by":"crossref","first-page":"12528","DOI":"10.1016\/S0021-9258(18)42309-5","article-title":"Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement","volume":"267","author":"Olson","year":"1992","journal-title":"J. Biol. Chem."},{"key":"2021120120544822700_B22","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"High-dose antithrombin III in severe sepsis. A randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"2021120120544822700_B23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00024382-200209000-00006","article-title":"DL","volume":"18","author":"Murakami","year":"2002","journal-title":"Shock"},{"key":"2021120120544822700_B24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1043661802001688","article-title":"The effects of antithrombin-III on inducible nitric oxide synthesis in experimental obstructive jaundice","volume":"46","author":"Pata","year":"2002","journal-title":"Pharmacol. Res."},{"key":"2021120120544822700_B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00075198-200102000-00001","article-title":"Neutrophil activation and acute lung injury","volume":"7","author":"Lee","year":"2001","journal-title":"Curr. Opin. Crit. Care"},{"key":"2021120120544822700_B26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.4049\/jimmunol.160.2.1007","article-title":"Neutrophils are major contributors to intraparenchymal lung IL-1\u03b2 expression after hemorrhage and endotoxemia","volume":"160","author":"Parsey","year":"1998","journal-title":"J. Immunol."},{"key":"2021120120544822700_B27","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4049\/jimmunol.163.2.954","article-title":"Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: Roles of reactive oxygen intermediates, NF-\u03baB, and cyclic AMP response element binding protein","volume":"163","author":"Shenkar","year":"1999","journal-title":"J. Immunol."},{"key":"2021120120544822700_B28","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1164\/rccm.200503-451OC","article-title":"Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers","volume":"172","author":"Maris","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021120120544822700_B29","doi-asserted-by":"crossref","first-page":"L1043","DOI":"10.1152\/ajplung.00305.2001","article-title":"Role of anti-L-selectin antibody in burn and smoke inhalation inury in sheep","volume":"283","author":"Katahira","year":"2002","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"2021120120544822700_B30","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1182\/blood.V99.11.4015","article-title":"Antithrombin III inhibits nuclear factor \u03baB activation in human monocytes and vascular endothelial cells","volume":"99","author":"Oelschlager","year":"2002","journal-title":"Blood"},{"key":"2021120120544822700_B31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1242\/jcs.115.1.227","article-title":"Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes","volume":"115","author":"Kaneider","year":"2002","journal-title":"J. Cell Sci."},{"key":"2021120120544822700_B32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-2999(95)00758-X","article-title":"Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin","volume":"297","author":"Fujii","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"2021120120544822700_B33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/jcb.21124","article-title":"Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis","volume":"100","author":"Brkovic","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"2021120120544822700_B34","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1084\/jem.20060375","article-title":"Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality","volume":"203","author":"Yano","year":"2006","journal-title":"J. Exp. Med."},{"key":"2021120120544822700_B35","first-page":"97","article-title":"Vascular permeability factor, vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis","volume":"237","author":"Dvorak","year":"1999","journal-title":"Curr. Topics Microbiol. Immunol."},{"key":"2021120120544822700_B36","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/brain\/awf257","article-title":"Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain","volume":"125","author":"Schoch","year":"2002","journal-title":"Brain"},{"key":"2021120120544822700_B37","doi-asserted-by":"crossref","first-page":"L360","DOI":"10.1152\/ajplung.00158.2002","article-title":"Decreased alveolar oxygen induces lung inflammation","volume":"284","author":"Madjdpour","year":"2003","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"2021120120544822700_B38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1165\/rcmb.2004-0407OC","article-title":"Thrombin impairs alveolar fluid clearance by promoting endocytosis of Na+,K+-ATPase","volume":"33","author":"Vadasz","year":"2005","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"2021120120544822700_B39","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1074\/jbc.270.22.13333","article-title":"Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia","volume":"270","author":"Levy","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2021120120544822700_B40","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"2021120120544822700_B41","doi-asserted-by":"crossref","first-page":"S329","DOI":"10.1097\/01.CCM.0000057912.71499.A5","article-title":"Anticoagulant therapy in acute lung injury","volume":"31","author":"Laterre","year":"2003","journal-title":"Crit. Care Med."},{"key":"2021120120544822700_B42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/138945007780362719","article-title":"Novel therapies for microvascular permeability in sepsis","volume":"8","author":"Jacobson","year":"2007","journal-title":"Curr. Drug Targets"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/114\/4\/321\/439231\/cs1140321.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/114\/4\/321\/439231\/cs1140321.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T17:37:33Z","timestamp":1684172253000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/114\/4\/321\/68609\/Combined-anticoagulants-ameliorate-acute-lung"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,15]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,2,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20070254","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,15]]}}}